Meeder Asset Management Inc Agenus Inc Transaction History

Meeder Asset Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$2.29 - $4.24 $34,727 - $64,299	-15,165 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$1.92 - $4.39 $31,585 - $72,219	-16,451 Reduced 52.03%	15,165 $38,000
Q4 2019 Feb 13, 2020	BUY	$2.41 - $4.4 $69,521 - $126,926	28,847 Added 1041.78%	31,616 $129,000
Q3 2019 Oct 17, 2019	SELL	$2.17 - $3.14 $10,988 - $15,900	-5,064 Reduced 64.65%	2,769 $7,000
Q2 2019 Aug 05, 2019	BUY	$2.53 - $3.04 $19,817 - $23,812	7,833 New	7,833 $24,000
Q1 2019 Apr 16, 2019	SELL	$2.51 - $3.73 $4,337 - $6,445	-1,728 Closed	0 $0
Q4 2018 Jan 17, 2019	BUY	$1.59 - $2.66 $500 - $837	315 Added 22.29%	1,728 $4,000
Q3 2018 Nov 02, 2018	BUY	$1.59 - $2.42 $2,246 - $3,419	1,413 New	1,413 $0
Q4 2017 Feb 02, 2018	SELL	$3.26 - $4.78 $1,480 - $2,170	-454 Closed	0 $0
Q3 2017 Oct 20, 2017	BUY	$3.48 - $4.44 $1,579 - $2,015	454	454 $2,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.